FDA requests removal of suicidal ideation warnings from GLP-1 RA labels after meta-analysis shows no increased risk compared with placebo.

A mobile phone application can characterize patterns of recovery from neurological manifestations of post-acute sequelae of severe acute respiratory syndrome co ...

An elevated neutrophil-to-lymphocyte ratio is associated with a significantly higher prevalence of depressive disorder.

The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.

Americans are signing up for Obamacare this year after extra financial help that lowered monthly premiums expired.

Circadian misalignment in adolescents is linked to structural changes in brain regions that regulate emotional processing and cognitive function.

The CASTLE Online Sleep Intervention may help reduce sleep onset latency for children with epilepsy when paired with standard ...

Epigenetic age acceleration appears to be associated with worse neurocognitive function for those that survive childhood ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2025. The list includes several groundbreaking therapies that are expected to change the ...

Interdisciplinary multimodal pain treatments yield small but clinically relevant improvements in pain and physical functioning for patients with chronic pain.

For older men, any amount, frequency, or severity of back pain appears to be predictive of subsequent sleep problems.

Multiple adverse prenatal exposures linked to altered developmental trajectories of psychopathology and cortical maturation ...